{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticancer agents", "Breast cancer", "Medicinal plants", "Phytochemicals", "Signaling pathways", "TNBC"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38327657", "DateRevised": {"Year": "2024", "Month": "02", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["103935", "10.1016/j.sjbs.2024.103935"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "20"}], "Journal": {"ISSN": "1319-562X", "JournalIssue": {"Volume": "31", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Saudi journal of biological sciences", "ISOAbbreviation": "Saudi J Biol Sci"}, "ArticleTitle": "Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation.", "Pagination": {"StartPage": "103935", "MedlinePgn": "103935"}, "Abstract": {"AbstractText": ["Cancer of the breast is the mainly prevalent class of cancer in females diagnosed over the globe. It also happens to be the 2nd most prevalent reason of cancer-related deaths among females worldwide. Some of the most common type's therapies for carcinoma of the breast involve radiation therapy, chemotherapy, and resection. Many studies are being conducted to develop new therapeutic strategies for better diagnosis of breast cancer. An enormous number of anticancer medications have been developed as a result of growing understanding of the molecular pathways behind the advancement of cancer. Over the past few decades, the general survival rate has not greatly increased due to the usage of chemically manufactured medications. Therefore, in order to increase the effectiveness of current cancer treatments, new tactics and cutting-edge chemoprevention drugs are required. Phytochemicals, which are naturally occurring molecules derived from plants, are important sources for both cancer therapy and innovative medication development. These phytochemicals frequently work by controlling molecular pathways linked to the development and spread of cancer. Increasing antioxidant status, inactivating carcinogens, preventing proliferation, causing cell cycle arrest and apoptosis, and immune system control are some of the specific ways. This primary objective of this review is to provide an overview of the active ingredients found in natural goods, including information on their pharmacologic action, molecular targets, and current state of knowledge. We have given a thorough description of a number of natural substances that specifically target the pathways linked to breast carcinoma in this study. We've conducted a great deal of study on a few natural compounds that may help us identify novel targets for the detection of breast carcinoma."], "CopyrightInformation": "\u00a9 2024 The Author."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Family and Community Medicine, Faculty of Medicine, Albaha University, Albaha, Saudi Arabia."}], "LastName": "Almilaibary", "ForeName": "Abdullah", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi J Biol Sci", "NlmUniqueID": "101543796", "ISSNLinking": "2213-7106"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Adler S.R., Fosket J.R. Disclosing complementary and alternative medicine use in the medical encounter. J. Fam. Pract. 1999;48(6):453\u2013458.", "ArticleIdList": ["10386489"]}, {"Citation": "Aggarwal R., et al. Natural compounds: role in reversal of epigenetic changes. Biochemistry (moscow) 2015;80(8):972\u2013989.", "ArticleIdList": ["26547065"]}, {"Citation": "Ahmad A., et al. Apoptosis-inducing effect of garcinol is mediated by NF-\u03baB signaling in breast cancer cells. J. Cell. Biochem. 2010;109(6):1134\u20131141.", "ArticleIdList": ["20108249"]}, {"Citation": "Ahmad A., et al. Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer CellsGarcinol Regulates EMT, miRNAs, and Wnt Signaling. Mol. Cancer Ther. 2012;11(10):2193\u20132201.", "ArticleIdList": ["PMC3836047", "22821148"]}, {"Citation": "Alharbi K.S., et al. Role of Medicinal plant-derived Nutraceuticals as a potential target for the treatment of breast cancer. J. Food Biochem. 2022;46(12):e14387.", "ArticleIdList": ["36121313"]}, {"Citation": "Antonescu Mintas A.I., et al. Perspectives on the Combined Effects of Ocimum basilicum and Trifolium pratense Extracts in Terms of Phytochemical Profile and Pharmacological Effects. Plants (basel) 2021;10(7)", "ArticleIdList": ["PMC8309466", "34371593"]}, {"Citation": "Atwell L.L., et al. Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy. Cancer Prev. Res. (Phila.) 2015;8(12):1184\u20131191.", "ArticleIdList": ["PMC4670794", "26511489"]}, {"Citation": "Bagley M.C., et al. Thiopeptide antibiotics. Chem. Rev. 2005;105(2):685\u2013714.", "ArticleIdList": ["15700961"]}, {"Citation": "Bahar M.E., et al. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct. Target. Ther. 2023;8(1):455.", "ArticleIdList": ["PMC10725898", "38105263"]}, {"Citation": "Bennouna J., et al. Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours. Ann. Oncol. 2003;14(4):630\u2013637.", "ArticleIdList": ["12649112"]}, {"Citation": "Bennouna J., et al. Vinflunine: a new microtubule inhibitor agent. Clin. Cancer Res. 2008;14(6):1625\u20131632.", "ArticleIdList": ["18347163"]}, {"Citation": "Bhat U.G., et al. FoxM1 is a general target for proteasome inhibitors. PLoS One. 2009;4(8):e6593.", "ArticleIdList": ["PMC2721658", "19672316"]}, {"Citation": "Bhattacharya S.K., et al. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J. Exp. Biol. 1997;35(3):236\u2013239.", "ArticleIdList": ["9332168"]}, {"Citation": "Boon H.S., et al. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7(1):1\u20137.", "ArticleIdList": ["PMC1851951", "17397542"]}, {"Citation": "Braguer, D., et al. Antitumor activity of vinflunine: effector pathways and potential for synergies. Elsevier.", "ArticleIdList": ["18538174"]}, {"Citation": "Burstein H.J., et al. Use of alternative medicine by women with early-stage breast cancer. N. Engl. J. Med. 1999;340(22):1733\u20131739.", "ArticleIdList": ["10352166"]}, {"Citation": "Chandrika B.B., et al. Hesperetin and naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors. Life Sci. 2016;160:47\u201356.", "ArticleIdList": ["27449398"]}, {"Citation": "Chen T., et al. Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells. J. Nat. Med. 2014;68(1):46\u201352.", "ArticleIdList": ["23564030"]}, {"Citation": "Chen H.Y., Chen X.Y. Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7/TAM cells: an experimental research. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013;33(4):488\u2013491.", "ArticleIdList": ["23841269"]}, {"Citation": "Chen L., Li C.I. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol. Biomark. Prev. 2015;24(11):1666\u20131672.", "ArticleIdList": ["PMC4633380", "26464428"]}, {"Citation": "Chirumbolo S., et al. Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways. Int. J. Mol. Sci. 2018;19(11)", "ArticleIdList": ["PMC6274856", "30424557"]}, {"Citation": "Coleman M.P., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD) Lancet Oncol. 2008;9(8):730\u2013756.", "ArticleIdList": ["18639491"]}, {"Citation": "Cook M.T. Mechanism of metastasis suppression by luteolin in breast cancer. Breast Cancer (dove Med Press) 2018;10:89\u2013100.", "ArticleIdList": ["PMC6003288", "29928143"]}, {"Citation": "Cortes J., et al. Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer. Ann. Oncol. 2018;29(4):881\u2013887.", "ArticleIdList": ["29481630"]}, {"Citation": "Dewi C., et al. Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line. Molecules. 2022;27(12):3661.", "ArticleIdList": ["PMC9227697", "35744786"]}, {"Citation": "Dixon R.A., Ferreira D. Genistein. Phytochemistry. 2002;60(3):205\u2013211.", "ArticleIdList": ["12031439"]}, {"Citation": "Doyle L.A., et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. 1998;95(26):15665\u201315670.", "ArticleIdList": ["PMC28101", "9861027"]}, {"Citation": "El-Tanani M., et al. Ran GTPase and its importance in cellular signaling and malignant phenotype. Int. J. Mol. Sci. 2023;24(4):3065.", "ArticleIdList": ["PMC9968026", "36834476"]}, {"Citation": "Fan P., et al. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Res. Ther. 2013;4(6):1\u201310.", "ArticleIdList": ["PMC4054948", "24331293"]}, {"Citation": "Fv Torquato H., et al. Anti-cancer Phytometabolites targeting cancer stem cells. Curr. Genomics. 2017;18(2):156\u2013174.", "ArticleIdList": ["PMC5345336", "28367074"]}, {"Citation": "Grogan P.T., et al. Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Invest. New Drugs. 2014;32(4):604\u2013617.", "ArticleIdList": ["PMC4380174", "24718901"]}, {"Citation": "Gupta G.K., et al. Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies. Cancers. 2020;12(9):2392.", "ArticleIdList": ["PMC7565566", "32846967"]}, {"Citation": "Hahm E.R., Singh S.V. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Cancer Lett. 2013;334(1):101\u2013108.", "ArticleIdList": ["PMC3530008", "22935676"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u2013674.", "ArticleIdList": ["21376230"]}, {"Citation": "Hashem S., et al. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed. Pharmacother. 2022;150", "ArticleIdList": ["35658225"]}, {"Citation": "Hegde N.S., et al. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat. Chem. 2011;3(9):725\u2013731.", "ArticleIdList": ["21860463"]}, {"Citation": "Heinonen S.M., et al. Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. J. Agric. Food Chem. 2004;52(22):6802\u20136809.", "ArticleIdList": ["15506819"]}, {"Citation": "Henderson J.W., Donatelle R.J. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern. Ther. Health Med. 2004;10(1)", "ArticleIdList": ["14727500"]}, {"Citation": "Iqbal A., Sharif M. BTS-ST: Swin transformer network for segmentation and classification of multimodality breast cancer images. Knowl.-Based Syst. 2023;267"}, {"Citation": "Jan N., et al. Targeting Breast Cancer Stem Cells through Retinoids: A New Hope for Treatment. Crit. Rev. Oncol. Hematol. 2023", "ArticleIdList": ["37827439"]}, {"Citation": "Jiang M., et al. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer. Mol. Pharm. 2017;14(11):3628\u20133635.", "ArticleIdList": ["28895735"]}, {"Citation": "Kamaruzman N.I., et al. siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways. Biomedicines. 2018;6(3)", "ArticleIdList": ["PMC6164725", "29932151"]}, {"Citation": "Kanaze F.I., et al. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 2007;61(4):472\u2013477.", "ArticleIdList": ["17047689"]}, {"Citation": "Ko E.-Y., Moon A. Natural products for chemoprevention of breast cancer. J. Cancer Prevent. 2015;20(4):223.", "ArticleIdList": ["PMC4699749", "26734584"]}, {"Citation": "Kongtawelert P., et al. Inhibitory effect of hesperidin on the expression of programmed death ligand (PD-L1) in breast cancer. Molecules. 2020;25(2):252.", "ArticleIdList": ["PMC7024188", "31936263"]}, {"Citation": "Kruczynski A., et al. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem. Pharmacol. 1998;55(5):635\u2013648.", "ArticleIdList": ["9515574"]}, {"Citation": "Kruczynski A., et al. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. Eur. J. Cancer. 2006;42(16):2821\u20132832.", "ArticleIdList": ["16973349"]}, {"Citation": "Kruczynski A., Hill B.T. Vinflunine, the latest Vinca alkaloid in clinical development: a review of its preclinical anticancer properties. Crit. Rev. Oncol. Hematol. 2001;40(2):159\u2013173.", "ArticleIdList": ["11682323"]}, {"Citation": "Kundu J.K., Surh Y.J. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med. 2012;52(9):2013\u20132037.", "ArticleIdList": ["22391222"]}, {"Citation": "Kuo P.L., Lin C.C. Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci. 2003;73(2):243\u2013252.", "ArticleIdList": ["12738038"]}, {"Citation": "Lan J., et al. Design and synthesis of novel C(14)-urea-tetrandrine derivatives with potent anti-cancer activity. Eur. J. Med. Chem. 2018;143:1968\u20131980.", "ArticleIdList": ["29133049"]}, {"Citation": "Landis-Piwowar K.R., et al. Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. J. Cell. Biochem. 2008;105(2):514\u2013523.", "ArticleIdList": ["PMC2574743", "18636546"]}, {"Citation": "Latocha M., et al. Transcripional activity of genes encoding MMPs and TIMPs in breast cancer cells treated by genistein and in normal cancer-associated fibroblasts-in vitro studies. Acta Pol. Pharm. 2014;71(6):1095\u20131102.", "ArticleIdList": ["25745786"]}, {"Citation": "Lee D.E., et al. 7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase. J. Biol. Chem. 2010;285(28):21458\u201321466.", "ArticleIdList": ["PMC2898435", "20444693"]}, {"Citation": "Lee W., et al. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol. Appl. Pharmacol. 2012;262(1):91\u201398.", "ArticleIdList": ["22561332"]}, {"Citation": "Lee I.-C., Choi B.Y. Withaferin-A\u2014A natural anticancer agent with pleitropic mechanisms of action. Int. J. Mol. Sci. 2016;17(3):290.", "ArticleIdList": ["PMC4813154", "26959007"]}, {"Citation": "Li Y., et al. Epigenetic reactivation of estrogen receptor-\u03b1 (ER\u03b1) by genistein enhances hormonal therapy sensitivity in ER\u03b1-negative breast cancer. Mol. Cancer. 2013;12:9.", "ArticleIdList": ["PMC3577460", "23379261"]}, {"Citation": "Li Y., et al. Dietary natural products for prevention and treatment of breast cancer. Nutrients. 2017;9(7):728.", "ArticleIdList": ["PMC5537842", "28698459"]}, {"Citation": "Liu Y., et al. Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism. Int. J. Oncol. 2016;48(3):1063\u20131072.", "ArticleIdList": ["26794366"]}, {"Citation": "MacMahon B., et al. Etiology of human breast cancer: a review. J. Natl Cancer Inst. 1973;50(1):21\u201342.", "ArticleIdList": ["4571238"]}, {"Citation": "Malik F., et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis. 2007;12(11):2115\u20132133.", "ArticleIdList": ["17874299"]}, {"Citation": "Manoharan S., et al. Circadian time-dependent chemopreventive potential of withaferin-A in 7, 12-dimethylbenz [a] anthracene-induced oral carcinogenesis. Pharmacol. Rep. 2009;61(4):719\u2013726.", "ArticleIdList": ["19815955"]}, {"Citation": "Manoharan S., et al. Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters. Indian J. Exp. Biol. 2009;47(1):16\u201323.", "ArticleIdList": ["19317347"]}, {"Citation": "Mayola E., et al. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis. 2011;16(10):1014\u20131027.", "ArticleIdList": ["21710254"]}, {"Citation": "Mehraj U., et al. Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemother. Pharmacol. 2021;87(2):147\u2013158.", "ArticleIdList": ["33420940"]}, {"Citation": "Mehraj U., et al. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cell. Oncol. 2021:1\u201321.", "ArticleIdList": ["34528143"]}, {"Citation": "Mehraj U., et al. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives. Breast Cancer. 2021;28(3):539\u2013555.", "ArticleIdList": ["33661479"]}, {"Citation": "Mehraj U., et al. Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis. Adv. Cancer Biol.-Metastasis. 2022;4"}, {"Citation": "Mehraj U., et al. Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941. Front. Pharmacol. 2022;13", "ArticleIdList": ["PMC9393306", "36003501"]}, {"Citation": "Mehraj U., et al. Clinicopathological Significance and Expression pattern of Bcl2 in Breast Cancer: A comprehensive in silico and in vitro Study. Saudi J. Biol. Sci. 2023", "ArticleIdList": ["PMC10787292", "38223131"]}, {"Citation": "Mehraj, U., et al., 2022. Adapalene and doxorubicin synergistically promote apoptosis of TNBC Cells by hyperactivation of the ERK1/2 pathway through ROS induction. Front. Oncol. 12.", "ArticleIdList": ["PMC9298514", "35875119"]}, {"Citation": "Mehraj, U., et al., 2022. Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells-An in vitro and in silico Study. Anti-cancer Agents Med. Chem.", "ArticleIdList": ["35440335"]}, {"Citation": "Miller A.B., Bulbrook R.D. The epidemiology and etiology of breast cancer. N. Engl. J. Med. 1980;303(21):1246\u20131248.", "ArticleIdList": ["7421960"]}, {"Citation": "Min K.-J., et al. Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells. Int. Immunopharmacol. 2011;11(8):1137\u20131142.", "ArticleIdList": ["21396905"]}, {"Citation": "Mir M.A., et al. Targeting different pathways using novel combination therapy in triple negative breast Cancer. Curr. Cancer Drug Targets. 2020;20(8):586\u2013602.", "ArticleIdList": ["32418525"]}, {"Citation": "Mir M.A., et al. Recent advances in chemotherapeutic implications of deguelin: a plant-derived retinoid. Nat. Products J. 2021;11(2):169\u2013181."}, {"Citation": "Mir, M.A., Agrewala, J.N., 2008. Dietary polyphenols in modulation of the immune system. Polyphenols and Health: New and Recent Advances. Nova Publishers, 245."}, {"Citation": "Mohan R., et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 2004;7(2):115\u2013122.", "ArticleIdList": ["15516832"]}, {"Citation": "Moon Y.J., et al. Effects of flavonoids genistein and biochanin a on gene expression and their metabolism in human mammary cells. Nutr. Cancer. 2007;57(1):48\u201358.", "ArticleIdList": ["17516862"]}, {"Citation": "Moon Y.J., et al. Biochanin A inhibits breast cancer tumor growth in a murine xenograft model. Pharm. Res. 2008;25(9):2158\u20132163.", "ArticleIdList": ["18454305"]}, {"Citation": "Munagala R., et al. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis. 2011;32(11):1697\u20131705.", "ArticleIdList": ["21859835"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79(3):629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Nobili S., et al. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 2009;59(6):365\u2013378.", "ArticleIdList": ["19429468"]}, {"Citation": "Panjamurthy K., et al. Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7, 12-dimethylbenz (a) anthracene-induced experimental oral carcinogenesis. Invest. New Drugs. 2009;27(5):447\u2013452.", "ArticleIdList": ["19009234"]}, {"Citation": "Park E.-J., et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett. 2009;277(2):133\u2013140.", "ArticleIdList": ["19135778"]}, {"Citation": "Pons D.G., et al. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J. Cell. Biochem. 2014;115(5):949\u2013958.", "ArticleIdList": ["24375531"]}, {"Citation": "Qayoom H., et al. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future Oncol. 2021;17(31):4185\u20134206.", "ArticleIdList": ["34342489"]}, {"Citation": "Qayoom H., et al. Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Med. Oncol. 2022;39(10):1\u201313.", "ArticleIdList": ["35870089"]}, {"Citation": "Qayoom H., et al. Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation. Saudi J. Biol. Sci. 2023;30(7)", "ArticleIdList": ["PMC10329161", "37425621"]}, {"Citation": "Qayoom H., et al. A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer. Med. Oncol. 2023;40(7):202.", "ArticleIdList": ["37308611"]}, {"Citation": "Qayoom H., et al. Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation. Saudi J. Biol. Sci. 2023;30(12)", "ArticleIdList": ["PMC10641555", "37964781"]}, {"Citation": "Qayoom H., et al. Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunol. Res. 2023;71(4):588\u2013599.", "ArticleIdList": ["37004645"]}, {"Citation": "Qiu T., et al. Exploring the Mechanism of Flavonoids Through Systematic Bioinformatics Analysis. Front. Pharmacol. 2018;9:918.", "ArticleIdList": ["PMC6104453", "30158870"]}, {"Citation": "Rampogu S., et al. Phytotherapeutic applications of alkaloids in treating breast cancer. Biomed. Pharmacother. 2022;155", "ArticleIdList": ["36271547"]}, {"Citation": "Ranjan A., et al. Role of phytochemicals in cancer prevention. Int. J. Mol. Sci. 2019;20(20):4981.", "ArticleIdList": ["PMC6834187", "31600949"]}, {"Citation": "Saadat, N., Gupta, S.V., 2012. Potential role of garcinol as an anticancer agent. J. Oncol. 2012.", "ArticleIdList": ["PMC3382268", "22745638"]}, {"Citation": "Sanchez-Vega F., et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321\u2013337.e310.", "ArticleIdList": ["PMC6070353", "29625050"]}, {"Citation": "Sehdev V., et al. Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells. J. Oncol. 2009;2009", "ArticleIdList": ["PMC2821773", "20169097"]}, {"Citation": "Shanmugam, M.K., et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds, Elsevier.", "ArticleIdList": ["27038646"]}, {"Citation": "Shoeb M. Anti-cancer agents from medicinal plants. Bangladesh J. Pharmacol. 2006;1(2):35\u201341."}, {"Citation": "Singh S.K., et al. Drug delivery approaches for breast cancer. Int. J. Nanomed. 2017;12:6205.", "ArticleIdList": ["PMC5576701", "28883730"]}, {"Citation": "Sofi S., et al. Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Med. Oncol. 2022;39(9):1\u201315.", "ArticleIdList": ["PMC9207877", "35723742"]}, {"Citation": "Sofi S., et al. Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications. Med. Oncol. 2022;39(6):1\u201316.", "ArticleIdList": ["35486263"]}, {"Citation": "Sofi S., et al. Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation. Saudi J. Biol. Sci. 2023;30(9)", "ArticleIdList": ["PMC10477739", "37675062"]}, {"Citation": "SoRelle J.A., et al. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia. 2013;56(4):814\u2013824.", "ArticleIdList": ["23318585"]}, {"Citation": "Stan S.D., et al. Withaferin A causes FOXO3a-and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008;68(18):7661\u20137669.", "ArticleIdList": ["PMC2562581", "18794155"]}, {"Citation": "Steib K., et al. Mitochondria modify exercise-induced development of stem cell-derived neurons in the adult brain. J. Neurosci. 2014;34(19):6624\u20136633.", "ArticleIdList": ["PMC6608139", "24806687"]}, {"Citation": "Thaiparambil J.T., et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer. 2011;129(11):2744\u20132755.", "ArticleIdList": ["21538350"]}, {"Citation": "Ullah M.F. Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac. J. Cancer Prev. 2008;9(1):1\u20136.", "ArticleIdList": ["18439063"]}, {"Citation": "Vinod B.S., et al. Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2\u2013Akt axis. Cell Death Discovery. 2015;1(1):1\u20139.", "ArticleIdList": ["PMC4979566", "27551486"]}, {"Citation": "Vyas A.R., Singh S.V. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone. AAPS J. 2014;16(1):1\u201310.", "ArticleIdList": ["PMC3889529", "24046237"]}, {"Citation": "Wang Y., et al. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br. J. Nutr. 2008;99(2):303\u2013310.", "ArticleIdList": ["17761019"]}, {"Citation": "Wong V.K.W., et al. Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-\u03b1 Inhibition and mTOR-Dependent Mechanisms. Front. Pharmacol. 2017;8:351.", "ArticleIdList": ["PMC5462963", "28642707"]}, {"Citation": "Wu X.-L., et al. Wnt/\u03b2-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine. Expert Rev. Mol. Med. 2023;25:e21.", "ArticleIdList": ["37332167"]}, {"Citation": "Xiong L.G., et al. Epigallocatechin-3-gallate promotes healthy lifespan through mitohormesis during early-to-mid adulthood in Caenorhabditis elegans. Redox Biol. 2018;14:305\u2013315.", "ArticleIdList": ["PMC5635249", "28992589"]}, {"Citation": "Xu W., et al. Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro. Cancers (basel) 2011;3(2):2274\u20132285.", "ArticleIdList": ["PMC3757417", "24212809"]}, {"Citation": "Yang J.H., et al. Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. Toxicol. Appl. Pharmacol. 2014;274(2):293\u2013301.", "ArticleIdList": ["24211276"]}, {"Citation": "Yang N., et al. Inhibition of sonic hedgehog signaling pathway by thiazole antibiotic thiostrepton attenuates the CD44+/CD24-stem-like population and sphere-forming capacity in triple-negative breast cancer. Cell. Physiol. Biochem. 2016;38(3):1157\u20131170.", "ArticleIdList": ["26963129"]}, {"Citation": "Yap K.M., et al. Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects. Saudi J. Biol. Sci. 2021;28(12):6730\u20136747.", "ArticleIdList": ["PMC8626310", "34866972"]}, {"Citation": "Yardley D.A., et al. A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer. Cancer Invest. 2010;28(9):925\u2013931.", "ArticleIdList": ["20690806"]}, {"Citation": "Ye X., et al. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17\u03b2-estradiol. Asian Pac. J. Cancer Prev. 2014;15(12):5001\u20135007.", "ArticleIdList": ["24998578"]}, {"Citation": "Yu Y., et al. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem. Pharmacol. 2010;79(4):542\u2013551.", "ArticleIdList": ["PMC2794909", "19769945"]}, {"Citation": "Zhang L., et al. Antibiotic susceptibility of mammalian mitochondrial translation. FEBS Lett. 2005;579(28):6423\u20136427.", "ArticleIdList": ["16271719"]}, {"Citation": "Zhang X., et al. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement. Altern. Med. 2011;11(1):1\u201310.", "ArticleIdList": ["PMC3198756", "21978374"]}, {"Citation": "Zhang L., et al. Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation. Mol. Med. Rep. 2015;11(3):1820\u20131826.", "ArticleIdList": ["PMC4270317", "25385471"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "25"}, {"Year": "2024", "Month": "1", "Day": "8"}, {"Year": "2024", "Month": "1", "Day": "19"}, {"Year": "2024", "Month": "2", "Day": "8", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "2", "Day": "8", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "8", "Hour": "4", "Minute": "7"}, {"Year": "2024", "Month": "1", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38327657", "PMC10847379", "10.1016/j.sjbs.2024.103935", "S1319-562X(24)00013-5"]}}]}